US 11229679
Compositions for treating heart disease by inhibiting the action of mAKAPβ
granted A61KA61K31/519A61K31/7048
Quick answer
US patent 11229679 (Compositions for treating heart disease by inhibiting the action of mAKAPβ) held by Anchored RSK3 Inhibitors, LLC expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Anchored RSK3 Inhibitors, LLC
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/519, A61K31/7048, A61K31/713, A61K38/005